Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study.
about
Pharmacological treatment for antipsychotic-related constipationBotulinum toxin for the treatment of chronic idiopathic constipationTegaserod for the treatment of irritable bowel syndrome and chronic constipationPolyethylene glycol for chronic constipation in adultsEffects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipationConsensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment)Recent Updates on the Treatment of ConstipationCurrent developments in pharmacological therapeutics for chronic constipationTreatment for constipation: new and old pharmacological strategiesA randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.Colonic hypersensitivity is a major determinant of the efficacy of bloating treatment in constipation-predominant irritable bowel syndrome.Review article: the treatment of functional abdominal bloating and distension.Use of Prucalopride for Chronic Constipation: A Systematic Review and Meta-analysis of Published Randomized, Controlled TrialsEmerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation.Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipationAssessment of treatment response in chronic constipation clinical trialsA randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation.Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.Prucalopride-associated acute tubular necrosis.The impact of laxative use upon symptoms in patients with proven slow transit constipation.Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population.Bloating and functional gastro-intestinal disorders: where are we and where are we going?Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.Promotility medications--now and in the future.Current management strategies and therapeutic targets in chronic constipation.Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study.A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation.Epidemiology and management of chronic constipation in elderly patients.Review article: The role of serotonergic agents in the treatment of patients with primary chronic constipation.Pathophysiology, diagnosis and current management of chronic constipation.The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome.Effective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis.What's new: innovative concepts in inflammatory bowel disease.Drugs acting on serotonin receptors for the treatment of functional GI disorders.Gastrointestinal motility disorders: an update.Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis.Chronic constipation: advances in management.Tegaserod for treating chronic constipation in elderly patients.Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.
P2860
Q24194825-91FE2DBD-A062-42D1-BDF3-516A6401C62EQ24240995-E83A68CD-0356-48ED-8BD2-A7E173E1C61AQ24242922-8786EB77-1758-4007-B512-6865248DDEC2Q24245738-B2E082ED-2122-4A50-8C5C-FA64387EBF06Q24607588-F82F1CB4-C3AA-48CD-A886-B51CBAD77C29Q24633140-DB87E771-0598-48B3-AAFB-F3553131415BQ26820242-CDBEFFDA-374F-4B07-95A2-64CD91189DFCQ27025474-E8718797-8764-4954-8F3D-6C5C4C6943C9Q27027346-817A7DCF-804E-4787-9C83-9471AFFB050DQ33436983-C4703DE5-C4A3-4061-8BCC-54EB82D5F832Q33448962-1B273471-5DF3-4C11-92A3-9637710D4462Q33450132-87E469D3-FE1C-44EB-90AC-8375F9349D3EQ33467828-53AF598D-1E61-4DE6-9F38-A2ABE46D318BQ33586854-CD1D1F58-BC23-47D1-8045-1B543CC52CDDQ33695487-E9B939D6-F3E5-4C76-939C-FB5C35D6A5CFQ33733640-E3CAD69F-3BFC-489D-BEBC-573E15D2E638Q33788020-4F51406F-59AF-4D7C-8219-842C1FFCC6DFQ33916182-F4689018-3158-454E-A26B-49B9F218719EQ33958710-03BD1860-4BA8-4A45-A820-82F9E9972970Q34047629-10F424BA-E712-42DD-A1AC-039DF35F3496Q34072074-B1AB3A28-8AB9-4208-AD6C-2AA0906EDFFCQ34164734-B669D3F8-B62E-4556-ACB8-499DFF67A4BCQ34366956-20F08C7B-3042-4F54-B2EF-94B18F54F8ADQ34522966-9293D5E1-96DD-4512-BF8A-063DD5880EEDQ34548916-1FB010A2-C6D8-4392-AFD8-4337CB78EFD8Q34565704-DA9B4402-5DD6-4B9E-9421-401C124AAA7CQ34567186-DCD9F885-B823-4E12-90D5-2310F3D7AB82Q34638259-6EE40C99-2D68-4AA6-B140-C8931480F3A2Q35694427-2C4203EB-40D5-4DB3-BDD6-FD0056A0623BQ36321320-A9258109-D23B-4ABA-B757-C91DCEAB973EQ36386025-64A94C79-ECDF-4B25-BF8A-1FA1C9DCFE6BQ36407290-1ACFD7CC-1FDB-4D58-9D7C-298A294A525AQ36426025-B8CF8B02-D1BD-40E2-8090-B4857488B02EQ36440535-BE785A06-CB99-4A9E-8BDA-9CD953AD388AQ36478089-FA20C60F-1C78-4761-898E-E81D59F26297Q36540251-47141CB2-3456-4118-837E-C39BC4070BEAQ36555966-5E177E78-C303-4E5B-AA1B-692F45DB9151Q36691853-81828735-F1B9-4EC4-9A6E-915E3B4904ADQ36709761-9794EAA7-9683-45D5-BFD7-1C8127D2DFF2Q36728938-2DF3D84B-1376-48D6-9BF3-62A44B6CB17F
P2860
Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Tegaserod for the treatment of ...... ontrolled multinational study.
@en
Tegaserod for the treatment of ...... ontrolled multinational study.
@nl
type
label
Tegaserod for the treatment of ...... ontrolled multinational study.
@en
Tegaserod for the treatment of ...... ontrolled multinational study.
@nl
prefLabel
Tegaserod for the treatment of ...... ontrolled multinational study.
@en
Tegaserod for the treatment of ...... ontrolled multinational study.
@nl
P2093
P2860
P1476
Tegaserod for the treatment of ...... ontrolled multinational study.
@en
P2093
Andrey Kalinin
Brigitte Nault
Fiona Fordham
Guy Boeckxstaens
Jan Dzieniszewski
Michael A Kamm
Nicholas J Talley
Oleg N Minushkin
Peter Haeck
P2860
P304
P356
10.1111/J.1572-0241.2005.40749.X
P407
P577
2005-02-01T00:00:00Z